Anesthetic management in kidney transplantation part I. Preoperative and intraoperative recipient care.

Authors

  • Belén Cifuentes Garcia Resident Internal Physician of Anesthesiology and Intensive Care. Albacete University Hospital Complex. Spain.
  • Álvaro Iñiguez de Onzoño Pérez Specialist Physician in the Anesthesiology and Intensive Care Area. Albacete University Hospital Complex. Spain.
  • Jaime López- Torres López Specialist Physician in the Anesthesiology and Intensive Care Area. Albacete University Hospital Complex. Spain.
  • José Antonio Flores García Resident Internal Physician of Anesthesiology and Intensive Care. Albacete University Hospital Complex. Spain.

DOI:

https://doi.org/10.30445/rear.v14i3.1001

Keywords:

Kidney transplantation, preoperative care, intraoperative care, anesthesia, solid organ, solid organ recipient

Abstract

Kidney transplantation is the treatment of choice in end stage renal disease. This article provides an updated review about the anesthetic management in kidney transplantation with a special focus on preoperative and intraoperative care. The leading causes of death after kidney transplantation are cardiac complications, thus a cardiovascular examination is crucial in these patients. Regarding the intraoperative period, the most suitable drugs and hemodynamic management are reviewed. 

References

2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J. 2014 Sep 14;35(35):2383–431.

Mittel AM, Wagener G. Anesthesia for Kidney and Pancreas Transplantation. Anesthesiology Clinics. 2017 Sep;35(3):439–52.

Lentine KL, Costa SP, Weir MR, Robb JF, Fleisher LA, Kasiske BL, et al. Cardiac Disease Evaluation and Management Among Kidney and Liver Transplantation Candidates. Journal of the American College of Cardiology. 2012 Jul;60(5):434–80.

Kasiske BL, Snyder JJ, Matas AJ, Ellison MD, Gill JS, Kausz AT. Preemptive kidney transplantation: the advantage and the advantaged. J Am Soc Nephrol. 2002 May;13(5):1358–64.

Meier-Kriesche HU, Port FK, Ojo AO, Rudich SM, Hanson JA, Cibrik DM, et al. Effect of waiting time on renal transplant outcome. Kidney Int. 2000 Sep;58(3):1311–7.

Schmid S, Jungwirth B. Anaesthesia for renal transplant surgery: an update. European Journal of Anaesthesiology. 2012 Dec;29(12):552–8.

Calixto-Flores A, Román-Sánchez M, Jiménez-Sánchez E, Cruz-Santiago J, Meza-Jiménez G, Bernáldez-Gómez G. Evaluation of Renal Function at 24, 48, and 72 Hours and 3 Months After Transplant: Comparison of 3 Anesthetic Techniques. Transplantation Proceedings. 2020 May;52(4):1094–101.

Staals LM, Snoeck MMJ, Driessen JJ, van Hamersvelt HW, Flockton EA, van den Heuvel MW, et al. Reduced clearance of rocuronium and sugammadex in patients with severe to end-stage renal failure: a pharmacokinetic study†. British Journal of Anaesthesia. 2010 Jan 1;104(1):31–9.

Panhuizen IF, Gold SJA, Buerkle C, Snoeck MMJ, Harper NJN, Kaspers MJGH, et al. Efficacy, safety and pharmacokinetics of sugammadex 4 mg kg-1 for reversal of deep neuromuscular blockade in patients with severe renal impairment. Br J Anaesth. 2015 May;114(5):777–84.

Adams DR, Tollinche LE, Yeoh CB, Artman J, Mehta M, Phillips D, et al. Short-term safety and effectiveness of sugammadex for surgical patients with end-stage renal disease: a two-centre retrospective study. Anaesthesia. 2020;75(3):348–52.

Gonsowski CT, Laster MJ, Eger EI, Ferrell LD, Kerschmann RL. Toxicity of compound A in rats. Effect of a 3-hour administration. Anesthesiology. 1994 Mar;80(3):556–65.

Ebert TJ, Arain SR. Renal responses to low-flow desflurane, sevoflurane, and propofol in patients. Anesthesiology. 2000 Dec;93(6):1401–6.

Lee HT, Ota-Setlik A, Fu Y, Nasr SH, Emala CW. Differential protective effects of volatile anesthetics against renal ischemia-reperfusion injury in vivo. Anesthesiology. 2004 Dec;101(6):1313–24.

Motayagheni N, Phan S, Eshraghi C, Nozari A, Atala A. A Review of Anesthetic Effects on Renal Function: Potential Organ Protection. Am J Nephrol. 2017;46(5):380–9.

Lugo-Baruqui JA, Ayyathurai R, Sriram A, Pragatheeshwar KD. Use of Mannitol for Ischemia Reperfusion Injury in Kidney Transplant and Partial Nephrectomies—Review of Literature. Curr Urol Rep. 2019 Jan;20(1):6.

Sandal S, Bansal P, Cantarovich M. The evidence and rationale for the perioperative use of loop diuretics during kidney transplantation: A comprehensive review. Transplantation Reviews. 2018 Apr 1;32(2):92–101.

Weinberg L, Harris L, Bellomo R, Ierino FL, Story D, Eastwood G, et al. Effects of intraoperative and early postoperative normal saline or Plasma-Lyte 148® on hyperkalaemia in deceased donor renal transplantation: a double-blind randomized trial. Br J Anaesth. 2017 Oct 1;119(4):606–15.

Pfortmueller C, Funk G-C, Potura E, Reiterer C, Luf F, Kabon B, et al. Acetate-buffered crystalloid infusate versus infusion of 0.9% saline and hemodynamic stability in patients undergoing renal transplantation : Prospective, randomized, controlled trial. Wien Klin Wochenschr. 2017 Sep;129(17–18):598–604.

Ciapetti M, di Valvasone S, di Filippo A, Cecchi A, Bonizzoli M, Peris A. Low-Dose Dopamine in Kidney Transplantation. Transplantation Proceedings. 2009 Dec;41(10):4165–8.

Published

2022-04-04

How to Cite

Cifuentes Garcia, B., Iñiguez de Onzoño Pérez, Álvaro ., López- Torres López, J. ., & Flores García, J. A. . (2022). Anesthetic management in kidney transplantation part I. Preoperative and intraoperative recipient care. Revista Electrónica AnestesiaR, 14(3). https://doi.org/10.30445/rear.v14i3.1001

Most read articles by the same author(s)